Day: June 12, 2020

SAN DIEGO, June 12, 2020 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced that it prepaid in full its outstanding term loans on June 12, 2020.The prepaid debt, comprised of an initial $100 million term loan and an additional $20 million term loan from certain funds affiliated with Oaktree Capital Management, L.P., was obtained pursuant to a Term Loan Agreement entered into in November 2018.About Sorrento Therapeutics, Inc. Sorrento is a clinical stage, antibody-centric, biopharmaceutical company developing new therapies to treat cancers. Sorrento’s multimodal multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as fully human antibodies (“G-MAB™ library”), clinical stage immuno-cellular therapies...

IONE, CA, June 12, 2020 (GLOBE NEWSWIRE) — Purebase Corporation (OTCQB: PUBC), a diversified resource company, headquartered in Ione, California, today announces that it has closed on a transaction to acquire a large-scale mineral processing plant from the Quove Corporation. The definitive agreement was signed May 1st, 2020, and both sides have met the qualifications to close as of June 11th, 2020.Purebase’s President and CEO, Scott Dockter stated, “These components are key pieces of our production facility for the near-term commercialization of supplemental cementitious material “SCM” into the West Coast.”About Purebase CorporationPurebase Corporation (OTCQB: PUBC) is a diversified resource company that acquires, develops and markets minerals for use in the agriculture, construction and other specialty industries.ContactsEmilyTirapelle...

Orlando, Florida, June 12, 2020 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), the premier provider of influencer marketing technology, data, and services for the world’s leading brands, today announced the launch of Shake™, a new online marketplace that allows creators to offer their services, delivered digitally, for a self-determined price.  Influencers, photographers, writers, musicians, and more can use IZEA’s Shake to collaborate and transact with marketers and individual buyers. Creators list available “Shakes” on their accounts in the platform and marketers select and purchase creative packages from them through a streamlined chat experience, assisted by ShakeBot™ – a proprietary, artificial intelligence assistant.Early registration access to Shake for creators is available beginning today.“Shake represents...

Þann 30. apríl sl. var tilkynnt um breytingu á framkvæmdastjórn Haga, m.a. að Guðmundur Marteinsson, framkvæmdastjóri Bónus, hefði óskað eftir að láta af störfum hjá fyrirtækinu. Í dag hefur náðst samkomulag við Guðmund og mun hann áfram starfa sem framkvæmdastjóri Bónus.Í ársreikningi félagsins sem birtur var 18. maí sl. var tilkynnt að fjárhagsleg áhrif starfslokanna kæmu fram á fyrsta ársfjórðungi rekstrarársins 2020/21. Í ljósi fyrrgreinds samkomulags mun ekki koma til gjaldfærslu nú, líkt og áður hafði verið áætlað.Miðað við ofangreint gerir nú mat stjórnenda ráð fyrir því að rekstrarhagnaður fyrir afskriftir samstæðunnar (EBITDA) á fyrsta ársfjórðungi, þ.e. tímabilið 1. mars til 31. maí 2020, verði 1.100 til 1.250 millj. króna.Nánari upplýsingar veitir Davíð Harðarsson, stjórnarformaður Haga, í tölvupósti: davidh@nordicvisitor....

FUNDARBOÐAðalfundur Kaldalóns hf., kt. 490617-1320, verður haldinn föstudaginn 26. júní 2020, kl. 15:00, í höfuðstöðvum Kviku banka hf., Katrínartún 2, 105 Reykjavík,  9.hæð.Á dagskrá fundarins verða eftirfarandi liðir:Skýrsla stjórnar félagsins um starfsemi þess síðastliðið starfsár.Ársreikningur félagsins fyrir árið 2019 og ákvörðun um meðferð hagnaðar eða taps félagsins á reikningsárinu.Kosning og skipun stjórnar, varastjórnar og fjárfestingar- og hagsmunaráðs.Tillögur stjórnar um breytingar á samþykktum félagsins.Kjör endurskoðanda félagsins.Starfskjarastefna félagsins.Ákvörðun þóknunar til stjórnarmanna og endurskoðanda.Samantekt stjórnar um hlutafjáreign og samstæðutengsl.Umræður og atkvæðagreiðslur um önnur málefni sem löglega eru upp borin.***Tillögur stjórnar um breytingar á samþykktum félagsins:Stjórn leggur til breytingar á...

Niðurstöður aðalfundar Sláturfélags Suðurlands svf.Aðalfundur Sláturfélags Suðurlands var haldinn föstudaginn 12. júní 2020 kl. 15:00 að Goðalandi, Fljótshlíð.1. ÁrsreikningurAðalfundur samþykkti ársreikning félagsins vegna ársins 2019.2.  Tillaga stjórnar um vexti af stofnsjóði og greiðslu arðs samþykktStjórn Sláturfélags Suðurlands svf. leggur til við aðalfund að greiddur verði 12,66%  arður af B-deild stofnsjóðs þar af er verðbótaþáttur 2,66% skv. 1. mgr. 14. gr. samþykkta félagsins, alls kr. 22.797.411,- eða 0,13 kr. á hvern útgefin hlut. Jafnframt að reiknaðir verði 3,0% vextir á höfuðstól inneigna í A-deild stofnsjóðs, alls kr. 10.642.637,-  Arðleysisdagur er 15. júní og arðréttindadagur er 16. júní.  Greiðsludagur arðs er 24. júní n.k.3.  Tillaga stjórnar um breytingar á samþykktum félagsins samþykktStjórn Sláturfélags Suðurlands...

VANCOUVER, British Columbia, June 12, 2020 (GLOBE NEWSWIRE) — Novelion Therapeutics Inc. (“Novelion” or the “Company”) by Alvarez & Marsal Canada Inc., Novelion’s court appointed liquidator (the “Liquidator”) today provides an update on the Company’s voluntary liquidation process (the “Liquidation”) that started on January 16, 2020 (the “Effective Date”).Liquidation UpdateThe Liquidator is currently administering the Court-approved claims process, the purpose of which was to solicit claims against Novelion and its directors and officers. Written notice of the commencement of the Liquidation and the claims process to all known creditors of Novelion was published in major newspapers in Canada and the U.S. and was sent by the Liquidator to known and potential creditors of the Company. The deadline for filing claims with the Liquidator...

PARIS, June 12, 2020 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) (the “Company”) today announced that the notice and agenda and other documents for the Company’s Annual General Meeting of Shareholders to be held on June 29, 2020, at 16:00 CET (10:00 AM EDT), are available on its website at www.constellium.com and are available free of charge at the offices of the Company by contacting the Corporate Secretary at cstm.corporatesecretary@constellium.com.About ConstelliumConstellium (NYSE: CSTM) is a global sector leader that develops innovative, value added aluminium products for a broad scope of markets and applications, including aerospace, automotive and packaging. Constellium generated €5.9 billion of revenue in 2019.www.constellium.com

COPENHAGEN, Denmark, June 12, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company has entered into a new supply contract with Janssen Vaccines & Prevention B.V., part of the Janssen Pharmaceutical Companies of Johnson & Johnson valued at USD 13.9 million.Under the contract, Bavarian Nordic will manufacture and deliver bulk drug substance of its MVA-BN® Filo vaccine, which Janssen has licensed as part of its Ebola vaccine regimen.While manufacturing of the vaccines will be initiated in 2020, supply and invoicing will not occur until 2021. Hence the contract does not impact the Company’s financial guidance for the full year 2020. “We are pleased to continue our strong collaboration with Janssen,” said Paul Chaplin, President & CEO of Bavarian Nordic. “Ebola remains a significant threat to global...

KØBENHAVN, Danmark, 12. juni 2020 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har indgået en ny leveringskontrakt med Janssen Vaccines & Prevention B.V., en del af Janssen Pharmaceutical Companies of Johnson & Johnson til en værdi af USD 13,9 mio.I henhold til kontrakten vil Bavarian Nordic producere og levere bulkvaccine til selskabets MVA-BN® Filo vaccine, som Janssen har licenseret og som indgår i deres ebolavaccine.Produktionen af vacciner vil blive påbegyndt i 2020, men levering og fakturering sker først i 2021 og således påvirker kontrakten ikke selskabets finansielle forventninger til 2020.“Vi er glade for at fortsætte vores stærke samarbejde med Janssen,” udtaler Paul Chaplin, administrerende direktør for Bavarian Nordic. ”Ebola udgør fortsat en betydelig trussel mod den globale sundhed, og forsyningen...